Dixon Robert L JR sold $61K of ELV
Dixon Robert L JR sold 151 shares of Elevance Health, Inc. (ELV) at $401.77 on 2026-06-11.
How this was made
The 30-second read
Why it matters
The disclosure documents an open-market sale by a director; it does not include any new company performance, guidance, or regulatory/legal development.
Market read
Traders may note the insider sale, but the transaction size and lack of accompanying fundamental news make it unlikely to drive a sustained repricing.
What to watch
Director sales can be driven by diversification, taxes, or personal liquidity; without additional context, the signal-to-noise is low.
Background
The article is a primary-source SEC Form 4 insider transaction disclosure for Elevance Health, Inc.
Ticker impact
Elevance Health director Robert L. Dixon Jr. filed an open-market sale of 151 shares at ~$401.77 on 2026-06-11 (Form 4).
Minimal near-term impact; any effect is likely noise unless paired with other negative disclosures.
This is a small, non-10b5-1 open-market sale by a director with no accompanying company-specific catalyst or guidance change in the text.
Market effects
No sector read-through; single-company insider transaction with no operational/regulatory update.
None indicated.
None indicated.
Counterpoint
Because the filing notes no pre-arranged 10b5-1 plan, some traders may interpret it as a modest negative signal, even if the dollar amount is small.
Key entities
- issuerElevance Health, Inc.
Subject of the Form 4 insider transaction disclosure (ELV).
- insiderRobert L. Dixon Jr.
Director who sold 151 shares in an open-market transaction.
%252FElevance%252520Health%252520world%252520headquarters%252520By%252520jetcityimage.jpeg&w=3840&q=75)
